These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9855533)

  • 1. Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures.
    Mirza WU; Rak IW; Thadani VM; Cereghino JJ; Garnett WR; Brown LM; Zhang Y; Belendiuk GW
    Neurology; 1998 Dec; 51(6):1727-9. PubMed ID: 9855533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and effects on quality of life of twice-daily extended-release carbamazepine in adults with seizure disorders: an open-label, 12- to 36-month continuation study.
    Hogan RE; Garnett WR; Thadani VM;
    Clin Ther; 2003 Oct; 25(10):2586-96. PubMed ID: 14667959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of Carbatrol to children with feeding tubes.
    Riss JR; Kriel RL; Kammer NM; Judge MK; Montgomery MJ
    Pediatr Neurol; 2002 Sep; 27(3):193-5. PubMed ID: 12393129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation.
    McLean A; Browne S; Zhang Y; Slaughter E; Halstenson C; Couch R
    J Clin Pharmacol; 2001 Feb; 41(2):183-6. PubMed ID: 11210399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.
    Mattson RH; Cramer JA; Collins JF
    N Engl J Med; 1992 Sep; 327(11):765-71. PubMed ID: 1298221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
    Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
    Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Ficker DM; Privitera M; Krauss G; Kanner A; Moore JL; Glauser T
    Neurology; 2005 Aug; 65(4):593-5. PubMed ID: 16116122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy].
    Czapiński P; Terczyński A
    Neurol Neurochir Pol; 1996; 30(3):419-26. PubMed ID: 8965976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case summary: Kate.
    Kirkham FJ; Ebbing A
    Seizure; 1994 Dec; 3 Suppl A():33-6. PubMed ID: 7894849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine- induced hypertension.
    Jette N; Veregin T; Guberman A
    Neurology; 2002 Jul; 59(2):275-6. PubMed ID: 12136070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients.
    Sobaniec W; Kułak W; Smigielska-Kuzia J; Boćkowski L; Majkowski J; Jedrzejczak J
    Pol J Pharmacol; 2004; 56(2):195-201. PubMed ID: 15156070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimizing the therapy of symptomatic partial epilepsy with sustained release carbamazepine].
    Vorob'eva OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(3):24-8. PubMed ID: 11490444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy.
    Doheny HC; Whittington MA; Jefferys JG; Patsalos PN
    Br J Pharmacol; 2002 Mar; 135(6):1425-34. PubMed ID: 11906955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.